Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Comprehensive Income (Loss)

v3.23.3
Condensed Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Condensed Statements of Comprehensive Income (Loss) [Abstract]        
License and collaborations revenue $ 11,935 $ 0 $ 17,358 $ 0
Operating expenses:        
General and administrative 2,055 1,703 8,680 5,215
Research and development 3,494 2,835 13,812 10,769
Total operating expenses 5,549 4,538 22,492 15,984
Income (loss) from operations 6,386 (4,538) (5,134) (15,984)
Financing costs (Note 6) (1,328) 0 (1,328) 0
Interest expense (Note 4) 0 0 0 (9)
Fair value change in derivative liability 61 0 61 0
Other income (expense), net 456 7 1,224 (60)
Income (loss) before income taxes 5,575 (4,531) (5,177) (16,053)
Provision for income taxes (14) 0 (14) 0
Net income (loss) 5,561 (4,531) (5,191) (16,053)
Other comprehensive income (loss), net of tax 0 0 0 0
Comprehensive income (loss) $ 5,561 $ (4,531) $ (5,191) $ (16,053)
Net income (loss) per share (Note 10):        
Basic (in dollars per share) $ 0.26 $ (0.22) $ (0.25) $ (0.82)
Diluted (in dollars per share) $ 0.25 $ (0.22) $ (0.25) $ (0.82)
Number of shares used in per share calculations:        
Basic (in shares) 21,446,648 20,498,229 21,117,211 19,635,651
Diluted (in shares) 22,405,995 20,498,229 21,117,211 19,635,651